SynCardia Systems Revenue and Competitors

Tucson, AZ USA

Location

$39.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SynCardia Systems's estimated annual revenue is currently $13.5M per year.(i)
  • SynCardia Systems received $14.0M in venture funding in December 2013.
  • SynCardia Systems's estimated revenue per employee is $155,000
  • SynCardia Systems's total funding is $39.4M.

Employee Data

  • SynCardia Systems has 87 Employees.(i)
  • SynCardia Systems grew their employee count by 12% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M620%N/AN/A
#3
$1.7M11-45%N/AN/A
#4
$5.3M340%N/AN/A
#5
$4M26-7%N/AN/A
#6
$2.5M16129%N/AN/A
#7
$1.4M9-25%N/AN/A
#8
$2.2M2921%$58.2MN/A
#9
$177M1142-6%N/AN/A
#10
$0.9M6200%N/AN/A
Add Company

SynCardia Systems, LLC (www.syncardia.com) in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart (TAH) is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® Portable Driver, which powers the SynCardia TAH and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

keywords:Healthcare,Medical Devices,Pharmaceuticals

$39.4M

Total Funding

87

Number of Employees

$13.5M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SynCardia Systems News

2022-04-17 - Heart Transplant Market Share 2022-2030| Key Players ...

The major players covered in Heart Transplant Markets: SynCardia Systems; HeartWare International; Calon Cardio; Optum; Apaxis Medical; Carmat...

2022-04-17 - Artificial Heart Market Size, Scope And Forecast | Thoratec ...

Thoratec Corporation, SynCardia Systems, Cirtec Medical Systems, BiVACOR, MyLVAD, CARMAT, Jarvik Heart, Abbott, AbioMed, Cleveland Heart.

2022-04-17 - Artificial Heart Market Will Hit Big Revenues In Future ...

Leading Manufacturers Analysis in Global Artificial Heart Market 2022: ? SynCardia Systems, BiVACOR, CARMAT, Abbott, Cleveland Heart, AbioMed,...

2014-10-14 - Syncardia ramping up production of its total artificial heart

The workings of Syncardia’s CardioWest heart are actually outlined nicely by NIH: A TAH usually extends life for months beyond what is expected with end-stage heart failure. If you’re waiting for a heart transplant, a TAH can keep you alive while you wait for a donor heart. A TAH also can impro ...

2014-07-17 - Press Release: FDA approves the freedom portable driver that powers the SynCardia total artificial heart

TUCSON, Ariz. — The Freedom portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable. Watch the story of two SynCardia Total Artificial Heart patie ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.4M880%N/A
#2
$8.8M8814%N/A
#3
$28.4M881%N/A
#4
$18.5M881%N/A
#5
$23.8M8835%N/A

SynCardia Systems Funding

DateAmountRoundLead InvestorsReference
2004-05-25$3.7MBArticle
2009-06-25$10.3MDHighway 12 VenturesArticle
2013-03-21$19.0MUndisclosedAthyrium Opportunities FundArticle
2013-12-18$14.0MUndisclosedWedbush PacGrow Life SciencesArticle